Cargando…

Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study

INTRODUCTION: Benefits and risks of preventive medication change over time for ageing patients and deprescribing of medication may be needed. Deprescribing of cardiovascular and antidiabetic drugs can be challenging and is not widely implemented in daily practice. OBJECTIVE: The aim of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abou, Jamila, Crutzen, Stijn, Tromp, Vashti, Heringa, Mette, Van Marum, Rob, Elders, Petra, Taxis, Katja, Denig, Petra, Hugtenburg, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934783/ https://www.ncbi.nlm.nih.gov/pubmed/35187614 http://dx.doi.org/10.1007/s40266-021-00918-7

Ejemplares similares

Barriers and Enablers of Older Patients to Deprescribing of Cardiometabolic Medication: A Focus Group Study
por: Crutzen, Stijn, et al.
Publicado: (2020)

Older people’s attitudes towards deprescribing cardiometabolic medication
por: Crutzen, Stijn, et al.
Publicado: (2021)

Development and Piloting of an Algorithm to Select Older Patients for Different Types of Medication Review
por: Crutzen, Stijn, et al.
Publicado: (2019)

Identifying patients at increased risk of hypoglycaemia in primary care: Development of a machine learning‐based screening tool
por: Crutzen, Stijn, et al.
Publicado: (2021)

Type 2 diabetes patients’ views on prevention of hypoglycaemia – a mixed methods study investigating self-management issues and self-identified causes of hypoglycaemia
por: Crutzen, Stijn, et al.
Publicado: (2021)

Differences in Older Patients' Attitudes Toward Deprescribing at Contextual and Individual Level
por: Oktora, Monika Pury, et al.
Publicado: (2022)

Patients’ Attitudes Towards Deprescribing Alpha-Blockers and Their Willingness to Participate in a Discontinuation Trial
por: Edelman, Malou, et al.
Publicado: (2019)

Deprescribing in cardiometabolic conditions in older patients: a systematic review
por: Hickman, Elizabeth, et al.
Publicado: (2023)

Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions
por: Hugtenburg, Jacqueline G, et al.
Publicado: (2013)

Challenges and Enablers of Deprescribing: A General Practitioner Perspective
por: Ailabouni, Nagham J., et al.
Publicado: (2016)

Identification of drug-related problems of elderly patients discharged from hospital
por: Ahmad, Abeer, et al.
Publicado: (2014)

Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes (T2D) in Indonesia: a cross-sectional survey study
por: Oktora, Monika Pury, et al.
Publicado: (2023)

Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review
por: Oktora, M. P., et al.
Publicado: (2020)

Validation of an Announced Telephone Pill Count Compared to a Home‐Visit Pill Count in People With Type 2 Diabetes or Cardiovascular Disease
por: Langendoen‐Gort, Marlous, et al.
Publicado: (2022)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands
por: Chau, Sek Hung, et al.
Publicado: (2015)

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands
por: de Vries, Esther, et al.
Publicado: (2020)

Amsterdam tool for clinical medication review: development and testing of a comprehensive tool for pharmacists and general practitioners
por: Mast, Ruth, et al.
Publicado: (2015)

Factors Associated With Nonadherence to Cardiovascular Medications: A Cross-sectional Study
por: van der Laan, Danielle M., et al.
Publicado: (2019)

Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle‐aged people treated for diabetes
por: Oktora, Monika Pury, et al.
Publicado: (2020)

Information on actual medication use and drug-related problems in older patients: questionnaire or interview?
por: Willeboordse, Floor, et al.
Publicado: (2016)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

The impact of cardiovascular medication use on patients’ daily lives: a cross-sectional study
por: van der Laan, Danielle M., et al.
Publicado: (2018)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: A qualitative study
por: En‐nasery ‐ de Heer, Selma, et al.
Publicado: (2022)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Opti-Med: the effectiveness of optimised clinical medication reviews in older people with ‘geriatric giants’ in general practice; study protocol of a cluster randomised controlled trial
por: Willeboordse, Floor, et al.
Publicado: (2014)

The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial
por: van der Laan, Danielle M., et al.
Publicado: (2017)

Effectiveness of a Patient-Tailored, Pharmacist-Led Intervention Program to Enhance Adherence to Antihypertensive Medication: The CATI Study
por: van der Laan, Danielle M., et al.
Publicado: (2018)

Implementation fidelity of an intervention programme to enhance adherence to antihypertensive medication in Dutch community pharmacies
por: van der Laan, Danielle M., et al.
Publicado: (2019)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022)

Symposium Abstract Deprescribing in Psychiatry
por: Mudgal, Varchasvi, et al.
Publicado: (2022)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies
por: Bosmans, Judith E., et al.
Publicado: (2019)

What Are the Drug-Related Problems Still Faced by Patients in Daily Life?—A Qualitative Analysis at the Pharmacy Counter
por: Kaae, Susanne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vmpgkg47dnhh2c50hc7pdp5cqu